Tag
Pioneering Australian melanoma doctor Richard Scolyer has died at 59 after undergoing a world-first experimental immunotherapy treatment for glioblastoma. His work with Georgina Long dramatically improved survival rates for advanced melanoma patients.
Researchers are testing CAR T cell therapy, originally designed for cancer, as a treatment for autoimmune diseases like multiple sclerosis, aiming to reset the immune system. The article follows a patient who received the experimental treatment.